Medication Continuity and Administration Worksheet

Purpose and elemental evidence map#

The statement “medication was withheld” may describe multiple, legally and clinically different situations: a pre-booking medication was not reported or verified; a licensed prescriber made an order to hold/change it; an equivalent medication was ordered and administered; an order reached the pharmacy but stock was unavailable; the pharmacy dispensed but the facility never delivered; an authorized health professional administered or a permitted staff member delivered a prescribed dispensed dose; the individual refused or could not access a medication pass; a dose was charted later, incorrectly or not at all; a transfer interrupted continuity; or new symptoms followed without established causation. Do not collapse these possibilities.

For each disputed medication build a MED-ID, identify the lawful document supporting each step, and preserve both favorable and contrary records. Use Roadmap 109 for custodians and medical records, 115 for symptoms/encounters, 116 for outside referrals and transfers, 119 for longitudinal clinical course and qualified causation review. An effective worksheet identifies where a decision originated, who had the ability to act, and what documentary fact would falsify each theory.

Separate chains: (1) community history → intake report → verification → reconciliation; (2) diagnosis/safety assessment → licensed prescriber order → clinical approval/formulary decision → pharmacy receipt and dispensing → facility delivery or administration → observed result or recorded nonadministration; (3) refill/monitoring, refusals, adverse effects, transfers and follow-up. Identify custody/clinical/pharmacy/contractor organizational roles by signed source, contract and delegation evidence; branding or a corporate family name alone cannot establish which entity controlled an event.

Key definitions from California Title 15. Section 1006 differentiates administering one dose from delivering prescribed, dispensed doses. Section 1216(b)(6) specifies administration by authorized licensed health personnel acting on a prescriber's order, while §1216(b)(7) permits medication delivery by licensed or nonlicensed personnel, including custody staff, on a prescriber's order. Thus a custody officer handing over dispensed medicine is not automatically proof of unauthorized administration. Distinct documentation and confirmation requirements in §1216(a) must be checked. These authorities concern eligible local detention facilities; state prison/hospital status and historical effective date require independent determination. [California 15 CCR §§1006, 1216; targeted secondary regulatory text reviewed 2026-10-19.]

Scope caveat: Neither a chart discrepancy nor a Title 15 procedural issue alone proves deliberate indifference, negligence, causation, municipal policy, CPOM interference or liability of any particular contractor. Legal review and clinical expert review are separate gates.

Record-control and lawful-acquisition key#

The historical H/R/D/P/K/X labels are retained only as possible access routes, not categorical legal entitlements. Mark more than one letter and annotate custodian and legal basis; a record can be existing, protected, and available to an authorized request simultaneously.

California vs federal patient-record timing. Under California HSC §123110, qualifying patient inspection and copy requests have their own statutory process (generally five working days for inspection and 15 days for copies when requirements apply). The HIPAA federal access rule at 45 CFR §164.524 generally calls for action within 30 days, subject to a qualified single written extension. Those are different pathways, not a universal guarantee of unrestricted jail-medication records. Under §164.524(a)(2)(ii) a correctional institution or covered provider acting under its direction may deny an inmate a copy on specifically identified security/safety grounds; that provision is not a blanket cancellation of all rights of inspection or every noninmate request. Record each claimed denial and the actual text invoked. California-specific exceptions and actual facility applicability remain open for counsel review. [Medical Board of California patient-access guidance; 45 CFR §164.524.]

Part 2 filter. For SUD treatment records first test whether they are maintained by a program/person subject to 42 CFR Part 2, rather than assuming that all opioid prescriptions or MOUD notes qualify. HHS reports the 2024 Part 2 final rule's compliance date was February 16, 2026; identify event date, covered program and lawful disclosure route. Part 2 confidentiality may constrain both private sharing and litigation evidence use. An access right never authorizes posting a completed PHI-filled worksheet publicly.

Medication identity, pre-booking baseline and provenance#

Use one unique MED-ID per pharmaceutical ingredient/formulation/route and a separate link for brand/generic, strength or therapeutic substitutions. Match identifiers rather than merely drug-name strings; a long-acting, immediate-release, depot, combination, oral and injected product are not interchangeable by name alone. Record what the contemporaneous source says, including dose units, frequency, as-needed indications, start/stop orders, allergies and actual fills. Do not infer ingestion from an active prescription or a pharmacy claim.

Source hierarchy and negative proof. Community medication list, pharmacist dispense history, prescriber's active orders, treatment notes and the individual's recall answer different questions. An empty refill history may reflect cash purchase or another pharmacy. A bottle photograph confirms only the bottle/label visible, not pharmacy fill, possession, ingestion or continued medical need. Compare identity, relevant dates and signature history; preserve records favorable to the defense, including a prior physician discontinuation, nonadherence, reported allergy or dose change. Do not create a fabricated “pre-booking active medication” from an outdated list.

Risk context for clinician review, not DIY dosing. Mark whether the records implicate time-sensitive therapies (e.g., insulin, seizure medicines, anticoagulation, anti-infectives, antiretrovirals, cardiovascular therapy, corticosteroids, psychotropics or medication for opioid use disorder) without declaring a fixed universal deadline. Pharmacology, last actual dose, physiology, interactions, indication and monitoring must be evaluated by a qualified clinician using the complete record. Record adverse and neutral medical evidence alike.

Booking and transfer reconciliation: separate every clock#

Create one row for each MED-ID at booking, intake, movement to another unit, jail-to-jail transfer, hospital admission, hospital discharge and release. Reconciliation is an activity; its absence from an available chart is a research question, not proof that no clinician considered the medication. Distinguish a medication reported by a patient from a medication verified by a pharmacy and a new signed provider order.

Clock protocol: record local clock as written, UTC offset if displayed, location, source system, exact precision and whether timestamp signifies creation, completion, author signature, interface transmission, receipt, correction, upload, or actual clinical event. Convert clocks only in a derived analysis field with method noted. Watch daylight-saving changes, cell transfers, custody logs and backdated order effective times. Do not treat late entry as inherently falsified documentation; authenticate amended audit trails and signatures where lawfully available.

Defensive tests: Could the medication have been stopped before booking? Did an alternate medication exist? Did the patient decline verification or report the wrong regimen? Did the facility receive a discharge summary promptly? What order was effective when a dose was allegedly due? Did an uncompleted medication list get imported from an obsolete hospitalization? Annotate factual disproof as prominently as affirmative evidence.

Prescribing, approval, formulary substitution and clinical authority#

Separate clinical decision (order, contraindication, diagnosis, intended regimen) from administrative implementation (stock, formulary exception, insurer/vendor contract, procurement, shift staffing, custody access). Title 15 §1200 assigns clinical judgments to qualified professionals while requiring the facility administrator to assure appropriate health care; that division does not by itself identify the actual party legally responsible for any event.

Do not equate “non-formulary” with denial of necessary care. Track the precise substitute, equivalence question, monitoring, reason and effect, not an unsupported judgment about appropriateness. Some discontinuations are medically compelled by interactions, renal/hepatic function, intoxication, possible overdose, bleeding, pregnancy or reassessment. Counsel/clinical review must evaluate contemporaneous records, relevant scope of practice, licensing and treatment availability. Administrative preference or cost considerations are potentially important only if actual decision-control and causal effect are demonstrated; don't infer CPOM violation from a single managed-care form.

Medication management regulations: Title 15 §1206(j) calls for written procedures addressing procurement, storage, repackaging, labeling, dispensing, administration/delivery and disposal. Section 1216(a) includes secure storage, recipient verification, confirming ingestion or self-administration accounting, documenting administered versus not administered doses and reasons, and annual pharmacist status reporting. Section 1216(b) distinguishes which personnel may procure, prepare, dispense, administer or deliver. Preserve applicable versions and actual facility policies; the public regulatory summary does not prove a policy was implemented at this jail or on this date.

Psychotropics and informed consent: Title 15 §1217 addresses emergency involuntary use, consent/capacity procedures, monitoring, and bans disciplinary administration. It is not a blanket rule that an incarcerated patient must receive every previous psychotropic prescription, nor an automatic authorization to involuntarily medicate without prescribed conditions. A contested case requires the actual informed-consent/capacity forms, order, emergency findings, monitoring and jurisdiction-specific authority. Do not use patient-specific mental-health details in public materials without independent review.

Pharmacy supply, dispensing, transport and handoff#

A medication may be ordered but never stocked; stocked but never dispensed for a patient; dispensed but not delivered to the appropriate unit; delivered by a nonlicensed person where §1216(b)(7) permits it; administered by authorized licensed health personnel; self-administered under narrow written protocols; or marked in the MAR despite contrary credible evidence. Distinguish each.

Personnel boundary: California Title 15 §1216(b)(6) permits administration only by licensed personnel authorized to administer, acting on a prescriber's order; §1216(b)(7) separately allows delivery by licensed or nonlicensed staff on the order. A note signed by a custody employee may therefore reflect delivery, not unauthorized injection/administration. Conversely, do not presume authorized administration occurred because a delivery log exists. Section 1216(d) restricts self-administration: reviewed text excludes controlled substances, psychotropics, injectables, TB therapy and drugs where documented ingestion is necessary. Determine policy, route and facility type; never claim a general right to keep all medicines at bedside.

MAR / eMAR dose-by-dose reconciliation#

Denominator matters. For each MED-ID build one row per scheduled dose/time, only for periods when the signed order actually made that dose due; account separately for PRN medicines, changing orders, scheduled holds, cancellations, NPO status, transport, discharge and facility policy. Do not call a blank MAR cell a confirmed missed dose without reconciling notes, backup paper MAR, pharmacy delivery, witness accounts, audit trail and chart conventions.

Disposition vocabulary (not legal conclusions): GIVEN_MARKED, OBSERVED_INGESTION, PATIENT_DISPUTES_GIVEN, REFUSED_MARKED, REFUSAL_CONTESTED, AUTHORIZED_HOLD, DRUG_UNAVAILABLE, PATIENT_UNAVAILABLE, LATE_MARKED, PRN_NOT_INDICATED, NO_ENTRY_IN_OBTAINED_FRAGMENT, MISSING_SOURCE_PAGE, CONFLICTING_SOURCES and UNRESOLVED. Keep raw code alongside translation. Distinguish no page produced from a blank row and a true absence of a scheduled order. Tally totals only after filtering each dose period by order and system completeness; report numerator, denominator, unknowns and data limitations.

Adverse/evidentiary control: An eMAR signature may reflect routine documentation, delayed legitimate completion, manual correction, wrong encounter or mistaken entry; challenge specific contradictions rather than accusing forgery by inference. Conversely, a patient recollection of not receiving medication may conflict with two contemporaneous independent witnesses or documentary proof of dispensing. Preserve both and request audit trails only through authorized means, under protective safeguards.

Refusals, holds, nonattendance, side effects and patient choice#

A refusal code is not equivalent to a medically informed voluntary refusal or an unlawful deprivation. Distinguish offered vs explained vs available vs accepted/rejected vs documented vs rescheduled. Also distinguish a prescriber-directed clinical hold from an unsanctioned administrative interruption. Current competence, capacity, security conditions and individual circumstances may be relevant; do not decide them from an isolated signature.

Suggested adverse checks: Document evidence of the patient intentionally declining a dose; lethargy/refusal due to clinical state; change in informed-consent preference; allergies, overdose risk, medication interaction, controlled-substance safety, order expiration, medical contraindication, court absence or emergency response. Conversely document whether an actual offer was possible, whether the patient's question was mis-coded as refusal, whether English/language or disability accommodations were available when needed, and whether medication-pass access was obstructed. No disputed refusal may be certified true or false without source assessment.

Consent distinction. Title 15 §1214 addresses informed consent policy, and §1217 adds psychotropic-specific emergency and capacity rules. An absence of a patient's wet signature is not by itself sufficient to conclude no valid informed consent, and a signature is not by itself sufficient to establish meaningful consent. Record actual legal, facility and clinical process.

Withdrawal, medication for opioid use disorder, and high-acuity monitoring#

Do not generalize protocols. Acute alcohol and sedative withdrawal, opioid withdrawal, discontinuation of long-standing MOUD, insulin interruption, seizures and abrupt psychotropic changes have different clinical risks. Record the pre-existing diagnosis, substances, provider order, actual screening, scores, objectively recorded findings, medically indicated monitoring, transfer options and documented response. The worksheet does not supply symptom-triggered drug doses or an algorithm.

Title 15 §1213 requires the responsible physician to develop written detoxification policies specifying in-facility versus licensed-facility transfer, including symptoms requiring urgent transfer. It separately requires facilities without medically licensed personnel attending not to retain patients with withdrawal reactions judged not readily controllable under the applicable policy; it does not dictate an identical regimen for every jail patient. Match the actual protocol effective at the relevant event date. Cross-reference §1206 and §§1207–1208 for screening/access and 1216 for medicine-handling systems.

Part 2 note. Special restrictions under federal 42 CFR Part 2 turn on covered-program status and event/disclosure date. The HHS 2024 final rule compliance date was February 16, 2026. A narcotic medication or mention of OUD does not establish Part 2 coverage; determine whether the program/record is within scope before any circulation, FOIA request, litigation compilation or public use. Do not substitute one patient's recovery narrative for verification of administration and clinical outcomes.

Transfers, court trips, unit moves, hospital discharge and release#

For each handoff identify which orders were actually active, who created the receiving medication list, how facility inventory/dispensed drugs moved, whether the individual could attend medication pass, whether a transport supply was authorized, the first new-unit dose and who received outside instructions. Title 15 §1206(n) addresses transfer of individualized health information and medication information; it does not prove compliance occurred. Compare hospital discharge instruction, jail re-entry reconciliation, pharmacy receipts and administration records in both systems. [See Worksheet 116.]

Medication effects, objective injury and causation worksheet#

Chronology is not medical causation. Link each alleged change, delay or missed dose to independently documented symptoms, vital signs, labs, adverse reactions, seizure/bleeding/withdrawal events, healthcare requests, provider reviews, hospital encounters and later recovery. Record baseline illness, co-occurring conditions, intercurrent injuries, nonadherence and alternative etiologies. Do not assert that a single undocumented dose or another brand would have prevented an event without clinically supported timing, mechanism and reliable expert review.

Organizational control and contrary explanations#

An EHR label, payroll employer, medication pass roster, county contract or prescription signed under one corporate logo does not alone allocate liability. Identify the responsible clinician, their privilege/employer relationship, pharmacy contractor, facility medical authority, custody chain and actual contracting party for the specific event, not the corporate enterprise in abstract. Do not presume Wellpath Management, Inc., CFMG, another Wellpath affiliate, a county employee or an individual medical director controlled every pharmacy and jail decision. Separate county enforcement/transport from clinical orders and independent dispensing contractors; retain contrary documentary ownership records.

Adverse defenses and falsification tests#

Legal-theory distinctions: For convicted prisoners, Farmer v. Brennan and Toguchi v. Chung caution that deliberate indifference requires more than negligence or disagreement over treatment. For pretrial detainees, Gordon v. County of Orange (2018) applies an objective Fourteenth Amendment standard, but more than negligence and affirmative causation are still required; the 2021 Gordon II disposition warns against unsupported Monell claims based on a single incident. Colwell, Jett and Peralta address interference, clinical circumstances, resources and harm, with fact- and defendant-specific limits. Examine Cleveland v. Ngo Chin (9th Cir. 2018), which remanded some allegations of retaliatory pain-medication discontinuation, but did not adjudicate every alleged medication lapse or establish automatic liability. No blanket “denied medication = constitutional violation” inference is permissible. All authorities require full current case-law citator and event-date checks before public use.

Evidence authentication, preservation and contradiction log#

Do not confuse an automatically computed hash with proof a record is truthful. Authenticity, completeness, custody, proper authorization, privilege, hearsay and ultimate admissibility are separate questions. Do not ask family members or staff to obtain unauthorized records. Identify gaps precisely without claiming destruction; follow Worksheet 114 for actual preservation obligations and Rule 37(e) prerequisites where applicable. Treat screenshots of identifiable patients as a protected record, not a public exhibit.

Instructions, practical evidence sequence and mandatory holds#

First preserve the original source in lawfully held form, record how acquired and the date range covered. Second link each MED-ID to intake, first signed order, pharmacy status, unit receipt, scheduled due intervals, MAR entry, any refusal/clinical hold, transfer and ensuing symptoms using documentary IDs. Third reconcile clocks and alternate records; keep the original code and the analytic translation side by side. Fourth write explicitly what remains unknown and where a defense-friendly source may explain a supposed gap. Fifth have qualified counsel address admissibility, privacy, government notice, claim/defendant and procedural questions and qualified clinicians assess medication/causation before any assertion of negligence or constitutional wrong.

Records requests: California HSC §123110, HIPAA 45 CFR §164.524, correctional access restrictions, HIPAA permissible correctional disclosures in §164.512(k)(5), Title 15 §1205, and Part 2 where applicable require separate applicability tests. In the federal rule the correctional exception concerns copies on specified security conditions; California's generally 15-day copy rule is not the same as HIPAA's generally 30-day action rule. Do not promise immediate access to correctional stock, dispensing contracts, other people's records, privileged documents or metadata merely because the MAR was requested. The medical board's patient records guidance concerns covered patient-provider relationships and cannot independently compel every correctional or nonparty entity. Preserve written responses/denials rather than treating an unanswered request as proof of concealment.

Editorial/privacy holds: This private candidate is not a template for posting populated rows. Before any dissemination separately review dates, unit locations, drug combinations, rare diagnoses, witness identities, staff identifying information, death/incarceration context, privilege, litigation hold/confidentiality, program-specific Part 2 rules and whether apparently deidentified details can be reidentified. No externally validated counsel/clinical or patient authorization has been recorded for A-117. Do not incorporate the worksheet into LEAP routes or a live repository without a separate staging and final authorization record.

Law-currentness access grading: Targeted official HHS and Medical Board guidance, Ninth Circuit opinion texts and university-hosted California regulatory reproductions were consulted on October 19, 2026. The official BSCC 2025 regulatory PDF was located but could not be accessed through the available browsing route; direct California October 2026 current CCR compilation and comprehensive Shepard's/KeyCite or equivalent subsequent-history verification are not established. The manuscript therefore cites California regulatory text with a PARTIAL / secondary-reproduction grade and cannot claim final regulatory authentication. No private facility medication policy, patient chart or authentic contract was inspected in this revision.

What this worksheet does not determine#

The manuscript cannot independently determine which medication should have been prescribed, whether a formulary substitution was clinically equivalent, whether a specific dose was swallowed, whether a refusal was informed, whether any staff member was qualified, whether a regulation applies to this facility on an event date, whether the county/CFMG/Wellpath entities controlled a decision, whether a claimed deprivation caused damage, whether another remedy must be exhausted, or whether any limitation/notice date was met. The record must be reviewed under the correct custody status and individual circumstances. It is intentionally not a dosing guide, medical diagnosis, litigation pleading, governmental finding, proof of wrongdoing, or publishable conclusion. A blanket statement about all patients or all contractors is expressly disallowed without supporting evidence.

Release conditions remaining OPEN: 2026 direct California text authentication; complete case citator and adverse authorities; actual custody/clinical/pharmacy source validation; source-B canonical and 092–095/096.1 precedence reconciliation; contextual PHI/privacy/privilege; independent clinician and counsel review; editorial and LEAP staging; a separate express final release decision. Mechanical patch integrity satisfies none of these.

Related roadmaps#

055 (receiving screening), 056 (reconciliation), 057 (medication management), 060–061 (withdrawal), 072 (refusal), 075 (clinical causation), 078 (legal defenses), 083 (patient records), 084 (discovery), 086 (contracts), 007/114 (preservation), 109 (record systems), 115 (encounters), 116 (off-site/transfer), 118 (mental health), 119 (course and causation), 120 (claim/notice sources), 130 (counsel package).

Private lineage: Source-A historical 117-medication-continuity-administration-worksheet.md was preserved without alteration. Source-B 100–124 body mapping, indexed 092–095 successors, alternate 096.1 precedence, missing revised A051, all privacy/privilege and outside reviews remain held. Protected pilot Roadmap 040, live kpsgill.com investigations and repository are untouched. NO MERGE, NO PUBLICATION, NO INTERIM CLAUDE HANDOFF.